Members

Blog Posts

Diễn đàn xem bong da Vebo TV sôi động

Posted by Vebo TV on June 28, 2022 at 11:41pm 0 Comments

Bóng đá được xem là môn thể thao để giải trí, sẽ thật bực mình nếu anh em phải xem những trận bóng gián đoạn. Đừng lo, Ve Bo TV bóng đá trực tuyến đỉnh cao này sẽ giúp bạn thỏa mãn cơn mê.

Diễn đàn sôi động bình luận bóng đá trực tiếp

Xem bóng đá nhất phải có bình luận, có dự đoán mới vui. Hơn nữa dự đoán tỉ số cũng là một cách thử thể hiện niềm am hiểu đá bóng sâu sắc của bạn. Thế nên Vebo Live đã mở ngay một mục bình luận bóng đá trước giờ thi đấu 45 phút.

Bài viết bình luận… Continue
Alex Wilson
  • Female
  • United States
Share on Facebook Share

Gifts Received

Gift

Alex Wilson has not received any gifts yet

Give a Gift

 

Alex Wilson's Page

Latest Activity

Alex Wilson posted a blog post

CHALLENGES AND OPPORTUNITIES FOR CELL LINE DEVELOPMENT AND CHARACTERIZATION SERVICE PROVIDERS

To request a sample copy / brochure of this report, please visit : https://www.rootsanalysis.com/reports/cell-line-development-and-characterization-services/request-sample.htmlCell lines have revolutionized scientific R&D and are currently being used for a myriad of applications.The development and characterization of cell lines is both technically challenging and…See More
Jun 22
Alex Wilson posted a blog post

The CAR-T therapies market is characterized by a healthy pipeline of promising therapies

Roots Analysis has announced the addition of “CAR-T Cell Therapy Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatocellular Carcinoma and Others), Target Antigens (CD19, BCMA, CD19 / CD22, GPC3 and EGFR), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World) – Industry Trends and Global…See More
Jun 20
Alex Wilson posted a blog post

The Avastin® biosimilars market is projected to witness noteworthy growth over the coming years

Roots Analysis has announced the addition of the (Avastin) Bevacizumab Biosimilars – Pipeline Review and Partnerships” report to its list of offerings.Biosimilars of bevacizumab are currently approved / being developed to treat colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, and cervical cancer. Experts believe that a strong biosimilar portfolio is equivalent to a blockbuster product, at least for companies with marketing power and reach; as a…See More
Jun 15
Alex Wilson posted a blog post

The antibody discovery services market is projected to be worth USD 6.5 billion by 2030

Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report to its list of offerings.The development of such biologics is inherently complex, and many drug developers are now seeking to optimize R&D efficiency and affiliated costs. As a result, innovator companies are outsourcing most of their discovery-stage operations to specialty contract research organizations (CROs), which offer a plethora of advanced technologies to…See More
Jun 9
Alex Wilson posted a blog post

Growing at an annualized rate of over 9%, the antibody discovery services market

Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report to its list of offerings.The development of such biologics is inherently complex, and many drug developers are now seeking to optimize R&D efficiency and affiliated costs. As a result, innovator companies are outsourcing most of their discovery-stage operations to specialty contract research organizations (CROs), which offer a plethora of advanced technologies to…See More
Jun 2
Alex Wilson posted a blog post

The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030, growing at a CAGR of 11%, claims Roots Analysis

Roots Analysis has announced the addition of “Handheld Imaging Devices Market, 2020-2030” report to its list of offerings.According to industry experts, handheld imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in…See More
May 30
Alex Wilson posted a blog post

The HUMIRA® biosimilars market is projected to witness considerable growth over the coming years, claims Roots Analysis

Roots Analysis has announced the addition of the “HUMIRA® (Adalimumab) Biosimilars – Pipeline Review and Partnerships” report to its list of offerings.Detailed review of the adalimumab biosimilars pipeline and affiliated developer landscape, featuring a list of involved innovator companies and their respective therapy candidates. It includes insights based on the current status of biosimilar candidates, and important developer related details (including headquarters, and type of…See More
May 26
Alex Wilson posted a blog post

The squamous non-small cell lung cancer market

Roots Analysis has announced the addition of “Squamous Non-small Cell Lung Cancer Market, 2021-2031” report to its list of offerings.Success of approved squamous non-small cell lung cancer therapies, such as Keytruda®, Opdivo® and Portrazza®, has resulted in a surge in interest of biopharmaceutical developers in this rapidly evolving domain. Presently, the ability of these therapies to effectively treat NSCLC, an aggressive form of squamous cell carcinoma, lung carcinoma, justifies its…See More
May 23
Alex Wilson posted a blog post

The soft tissue sarcoma market is projected to be worth over USD 420 million in 2030

Roots Analysis has announced the addition of “Soft Tissue Sarcoma: Focus on Angiosarcoma, Chondrosarcoma, and Liposarcoma Market, 2021-2030” report to its list of offerings.Soft tissue sarcoma is a rare form of cancer that usually originates in soft / connective tissues and most commonly affects the abdomen, arms, head, legs, neck and trunk of the individual. It is worth noting that, till date, many types (50+) of soft tissue sarcoma have been identified. However, since these tumors possess a…See More
May 9
Alex Wilson posted a blog post

CHALLENGES AND OPPORTUNITIES FOR CELL LINE DEVELOPMENT AND CHARACTERIZATION SERVICE PROVIDERS

In the past few years, there has been a significant surge in the demand for recombinant proteins and cellular systems for biomedical research, diagnostics and different therapies. In order to support the large- scale production and manufacturing of such cell- based products, there is an imperative need for the efficient development of high- quality stable cell lines. In fact, 60-70% of manufacturing processes of available biologics require live mammalian systems. A cell line refers to a defined…See More
May 2
Alex Wilson posted a blog post

The pharmaceutical secondary packaging market

Roots Analysis has announced the addition of “Pharmaceutical Secondary Packaging Market” report to its list of offerings.The anticipated growth in the therapeutics pipeline is likely to translate into a significant rise in the demand for cost-effective and quality secondary packaging solutions, presenting lucrative opportunities for contract packaging organizations. Driven by the growth of the overall pharmaceutical industry and increasing preference of drug developers for outsourcing certain…See More
Apr 25
Alex Wilson posted a blog post

The contract regulatory affairs-management services market for medical devices

Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CROs Market, 2019-2030.”The report features a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices. The study features an in-depth analysis, highlighting the capabilities of the various CROs engaged in this domain, across different regions of the globe. Amongst other elements, the report includes:  A detailed review of…See More
Apr 21
Alex Wilson posted a blog post

The biopreservation media providers market

Roots Analysis has announced the addition of “Biopreservation Media Providers Market” report to its list of offerings.Several companies across the globe are now offering a variety of biopreservation media that assist the transport and storage of cells, tissues and organs, across various preservation conditions. It is worth highlighting that such pre-formulated media ensure product quality, efficacy, viability and post preservation high cell recovery. Given the inclination of industry…See More
Apr 11
Alex Wilson posted blog posts
Apr 6
Alex Wilson posted a blog post

NOVEL OCULAR DRUG DELIVERY MARKET – GROWING INTEREST IN THE PHARMACEUTICAL INDUSTRY AND THE GROWING FUTURE POTENTIAL

The Novel Ocular Drug Delivery Devices Market report features an extensive study of the current market landscape and the likely adoption of novel ocular drug delivery devices, over the next decade. The study features a detailed analysis of the key drivers and trends related to this evolving domain.According to the World Health Organization (WHO), more than 2.2 billion individuals across the world suffer from some degree of vision impairment caused due to various ophthalmic disorders, such as…See More
Apr 5
Alex Wilson posted a blog post

Presence Of More Than 110 Service Providers Of Inhaled And Intranasal Drug Products Demonstrates The Popularity Of Outsourcing Trend

Amongst the total players having capability to offer services of inhaled and intranasal drug products, most of the players engaged in this domain are mid-sized firms. Of these, most of companies have been established before 2001. This is followed by the large firms of which, recently established large firms are (in alphabetical order) Kindeva Drug Delivery (2020) and Mapaex (2016).A detailed information visit this…See More
Apr 4

Alex Wilson's Blog

CHALLENGES AND OPPORTUNITIES FOR CELL LINE DEVELOPMENT AND CHARACTERIZATION SERVICE PROVIDERS

Posted on June 22, 2022 at 3:10am 0 Comments

To request a sample copy / brochure of this report, please visit : https://www.rootsanalysis.com/reports/cell-line-development-and-characterization-services/request-sample.html

Cell lines have revolutionized scientific R&D and are currently being used for a myriad of applications.

The development and characterization of cell lines is both technically…

Continue

The CAR-T therapies market is characterized by a healthy pipeline of promising therapies

Posted on June 20, 2022 at 3:07am 0 Comments

Roots Analysis has announced the addition of “CAR-T Cell Therapy Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatocellular Carcinoma and Others), Target Antigens (CD19, BCMA, CD19 / CD22, GPC3 and EGFR), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World) – Industry Trends and…

Continue

The Avastin® biosimilars market is projected to witness noteworthy growth over the coming years

Posted on June 15, 2022 at 2:36am 0 Comments

Roots Analysis has announced the addition of the (Avastin) Bevacizumab Biosimilars – Pipeline Review and Partnerships” report to its list of offerings.

Biosimilars of bevacizumab are currently approved / being developed to treat colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, and cervical cancer. Experts believe that a strong biosimilar portfolio is equivalent to a blockbuster product, at least for companies with marketing power and…

Continue

The antibody discovery services market is projected to be worth USD 6.5 billion by 2030

Posted on June 9, 2022 at 2:31am 0 Comments

Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report to its list of offerings.

The development of such biologics is inherently complex, and many drug developers are now seeking to optimize R&D efficiency and affiliated costs. As a result, innovator companies are outsourcing most of their discovery-stage operations to specialty contract research organizations (CROs), which offer a plethora of advanced…

Continue

Comment Wall

  • No comments yet!

You need to be a member of On Feet Nation to add comments!

Join On Feet Nation

 
 
 

© 2022   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service